RxDoctor Payments Data

Patricia Pagnotta

Adult Health · Maitland, FLNPI 1316048200

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $275,669 of the $409,253 with a category attached, or 67.4%. 60 manufacturers reported payments, led by EMD Serono, Inc. at 30.8% of the total. Among adult health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$409,253in general payments, 2019–2025

Across 1,830 payments — averaging $223.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$126K
  • AstraZeneca$64K
  • E.r. Squibb & Sons, L.L.C.$45K
  • Biogen$45K
  • Sanofi$38K
  • TG Therapeutics, Inc.$32K
  • plus $59K from 54 others
$31,350in research payments, 2019–2025

Across 7 payments — averaging $4478.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$31K
  • Sanofi$100

What the payments were for

  • Consulting fees$46,78911%
  • Speaking & faculty fees$275,66967%
  • Travel & lodging$50,16412%
  • Food & beverage$36,0989%
  • Education$5350%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.240$125,985
AstraZeneca148$63,980
E.r. Squibb & Sons, L.L.C.71$44,800
Biogen152$44,774
Sanofi84$38,045
TG Therapeutics, Inc.67$32,131
Bristol Myers Squibb65$12,045
Johnson & Johnson24$7,114
Mallinckrodt Hospital Products Inc.31$6,925
Amgen(2 entities)47$6,446
Genentech USA, Inc.89$6,159
Teva Pharmaceuticals USA, Inc.38$3,838
Merck Kgaa2$3,290
Neurocrine Biosciences, Inc.150$2,855
AbbVie(2 entities)149$2,274
Novartis124$890
UCB, Inc.32$718
Lundbeck LLC20$536
Lilly USA, LLC28$471
Eisai Inc.15$412
Argenx US, Inc.20$366
Supernus Pharmaceuticals, Inc.17$358
Pfizer16$326
Jazz Pharmaceuticals Inc.12$293
CSL Behring10$254
Tanabe Pharma America, Inc.12$224
Biohaven Pharmaceuticals, Inc.8$219
Scilex Pharmaceuticals Inc.12$219
Amneal Pharmaceuticals LLC14$219
Takeda Pharmaceuticals U.S.A., Inc.8$207
Otsuka America Pharmaceutical, Inc.9$192
GE HealthCare8$189
SK Life Science, Inc.7$188
Genentech, Inc.2$177
Sandoz2$164
Alnylam Pharmaceuticals Inc.6$151
Neurelis, Inc.8$146
Banner Life Sciences, LLC6$146
Catalyst Pharmaceuticals, Inc.5$144
Biohaven Pharmaceutical Holding Company Ltd.6$121
Sunovion Pharmaceuticals Inc.7$120
Grifols USA, LLC6$115
Acadia Pharmaceuticals Inc6$92
Upsher-smith Laboratories LLC4$85
Harmony Biosciences LLC3$72
Vanda Pharmaceuticals Inc.3$66
Xeris Pharmaceuticals, Inc.3$65
Kyowa Kirin, Inc.3$65
Sumitomo Pharma America, Inc.3$58
Acorda Therapeutics, Inc3$57
Avadel CNS Pharmaceuticals, LLC2$57
Averitas Pharma Inc.2$53
Livanova USA, Inc.3$52
Arbor Pharmaceuticals, Inc.4$51
Merz Pharmaceuticals, LLC1$26
Impel Pharmaceuticals Inc.1$23
Avanir Pharmaceuticals, Inc.1$23
Cala Health, Inc.1$21
Avion Pharmaceuticals1$20
Merck1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$409,253 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab11$113,563

Paid to pharmacies, not to this prescriber.

Other adult health in Maitland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →